Literature DB >> 17371264

Polyamines and neoplastic growth.

A E Pegg1, D J Feith.   

Abstract

Studies over many years have suggested that increased polyamine synthesis may be necessary for neoplastic growth. This review summarizes recent work on the regulation of putrescine production both de novo and via the degradation of higher polyamines and provides a summary of studies using transgenic mice in which the levels of proteins that regulate these processes (L-ornithine decarboxylase, antizyme and spermidine/spermine-N(1)-acetyltransferase) are altered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371264     DOI: 10.1042/BST0350295

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  26 in total

1.  Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N1, N11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells.

Authors:  Alison V Fraser; Andrew C Goodwin; Amy Hacker-Prietz; Elizabeth Sugar; Patrick M Woster; Robert A Casero
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

2.  Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients.

Authors:  Andrea Bandino; Dirk Geerts; Jan Koster; André S Bachmann
Journal:  Cell Oncol (Dordr)       Date:  2014-10-15       Impact factor: 6.730

3.  MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value.

Authors:  Mónica Rivera-Díaz; Miguel A Miranda-Román; Daniel Soto; Mario Quintero-Aguilo; Humberto Ortiz-Zuazaga; María J Marcos-Martinez; Pablo E Vivas-Mejía
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

4.  S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion.

Authors:  Chenxu Shi; Timothy K Cooper; Diane E McCloskey; Adam B Glick; Lisa M Shantz; David J Feith
Journal:  Carcinogenesis       Date:  2012-05-19       Impact factor: 4.944

5.  Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment.

Authors:  Candace S Hayes; Allyson C Shicora; Martin P Keough; Adam E Snook; Mark R Burns; Susan K Gilmour
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

6.  Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation.

Authors:  Ingo Lange; Dirk Geerts; David J Feith; Gabor Mocz; Jan Koster; André S Bachmann
Journal:  J Mol Biol       Date:  2013-10-01       Impact factor: 5.469

7.  Metabolism of N-alkylated spermine analogues by polyamine and spermine oxidases.

Authors:  Merja R Häkkinen; Mervi T Hyvönen; Seppo Auriola; Robert A Casero; Jouko Vepsäläinen; Alex R Khomutov; Leena Alhonen; Tuomo A Keinänen
Journal:  Amino Acids       Date:  2009-12-10       Impact factor: 3.520

8.  The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification.

Authors:  Dirk Geerts; Jan Koster; David Albert; Dana-Lynn T Koomoa; David J Feith; Anthony E Pegg; Richard Volckmann; Huib Caron; Rogier Versteeg; André S Bachmann
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

9.  Probenecid increases renal retention and antitumor activity of DFMO in neuroblastoma.

Authors:  Chad R Schultz; Matthew A Swanson; Thomas C Dowling; André S Bachmann
Journal:  Cancer Chemother Pharmacol       Date:  2021-06-15       Impact factor: 3.333

Review 10.  Antizyme and antizyme inhibitor, a regulatory tango.

Authors:  Chaim Kahana
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.